Trial
NCT05205161
A Phase I/II Study of AZD0466 as Monotherapy or in Combination With Anticancer Agents in Advanced Non-Hodgkin Lymphoma
Phase ITERMINATEDSAFETYConfidence: HIGH
Sponsor
AstraZeneca
Collaborators
—
Condition
Non-Hodgkin Lymphoma
Intervention
AZD0466
Why stopped
Due to safety reasons.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-01-07